Neuphoria Therapeutics (NEUP) Shares Issued (2023 - 2025)

Neuphoria Therapeutics (NEUP) has 3 years of Shares Issued data on file, last reported at $14.7 million in Q4 2025.

• Quarterly Shares Issued rose 3585006.6% year-over-year to $14.7 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $18.6 million (up 959.35% YoY) and the FY2025 annual result came in at $1.5 million, down 69.41% from the prior year.
• Shares Issued climbed to $14.7 million in Q4 2025 per NEUP's latest filing, from $3.3 million in the prior quarter.
• Across five years, Shares Issued topped out at $14.7 million in Q4 2025 and bottomed at -$3.0 million in Q2 2024.
• The 3-year median for Shares Issued is $823601.0 (2025), against an average of $2.7 million.
• The widest annual swing landed in 2024, when Shares Issued slumped 100.01%; it then surged 3585006.6% in 2025.
• Tracing NEUP's Shares Issued over 3 years: stood at $6.6 million in 2023, then plunged by 100.01% to -$409.0 in 2024, then surged by 3585006.6% to $14.7 million in 2025.
• Per Business Quant, the three latest NEUP Shares Issued figures stand at $14.7 million (Q4 2025), $3.3 million (Q3 2025), and $704675.0 (Q2 2025).

Peer Comparison